Kazia Therapeutics Limited
KZIA
$13.25
$3.1931.71%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 44.51% | 45.55% | -18.46% | -21.23% | -157.48% |
| Total Depreciation and Amortization | -100.06% | -100.07% | -0.03% | 2.32% | -1.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 54.73% | 51.83% | 199.62% | 206.65% | 298.23% |
| Change in Net Operating Assets | -120.46% | -120.08% | -230.06% | -233.09% | 380.42% |
| Cash from Operations | -45.47% | -42.75% | -32.91% | -36.01% | 49.57% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 204.41% | 204.41% | 108.62% | 108.62% | -82.88% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 4,260.22% | 4,260.22% | -- | -- | 86.08% |
| Cash from Financing | 392.46% | 383.19% | 104.91% | 109.69% | -82.93% |
| Foreign Exchange rate Adjustments | -192.72% | -191.01% | 190.76% | 192.72% | 34.72% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 165.37% | 164.13% | 183.80% | 185.75% | -320.98% |